On ECHEMI
Home > Drugs > ARDS
ARDS
Acute respiratory distress syndrome (ARDS) refers to acute, progressive hypoxic respiratory failure that occurs after severe infection, trauma, shock and other extrapulmonary attacks. It is mainly manifested by alveolar capillary damage and is a severe stage or type of acute lung injury (ALI). Its clinical features include respiratory rate and distress, progressive hypoxemia, and diffuse alveolar infiltration on X-rays. This disease is quite similar to infant respiratory distress syndrome, but its etiology and pathogenesis are not exactly the same, so the name of adult respiratory distress syndrome was proposed. It is now called acute respiratory distress syndrome, and the abbreviation is still ARDS.
  • Site of disease:

    lung
  • Infectious :

    Not contagious
  • Frequent population:

    All groups
  • Related symptoms:

    shortness of breath cardiogenic respiratory distress dyspnea respiratory distress syndrome shortness of breath after activity
  • Concurrent disease:

Related Drugs
Twenty-five-flavor lung disease pills
Manufacturer:

Xizang Xiongbalaqu Shenshui Xizangan Medicine Co., Ltd.

Nikethamide Injection
Indication: Used for central respiratory depression and respiratory depression caused by various reasons.
Manufacturer:

Reyoung Pharmaceutical Co., Ltd.

Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.